Improved Insulin Resistance and Lipid Metabolism by Cinnamon Extract through Activation of Peroxisome Proliferator‐Activated Receptors
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Peroxisome proliferator‐activated receptors (PPARs) are transcriptional factors involved in the regulation of insulin resistance and adipogenesis. Cinnamon, a widely used spice in food preparation and traditional antidiabetic remedy, is found to activate PPAR γ and α, resulting in improved insulin resistance, reduced fasted glucose, FFA, LDL‐c, and AST levels in high‐caloric diet‐induced obesity (DIO) and db/db mice in its water extract form. In vitro studies demonstrate that cinnamon increases the expression of peroxisome proliferator‐activated receptors γ and α (PPAR γ/α) and their target genes such as LPL, CD36, GLUT4, and ACO in 3T3‐L1 adipocyte. The transactivities of both full length and ligand‐binding domain (LBD) of PPAR γ and PPAR α are activated by cinnamon as evidenced by reporter gene assays. These data suggest that cinnamon in its water extract form can act as a dual activator of PPAR γ and α, and may be an alternative to PPAR γ activator in managing obesity‐related diabetes and hyperlipidemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Being a widely used spice, cinnamon has been found that it can lower sugar levels by improving the efficiency of insulin and glucose intake [30].”
From Nutritional and herbal interventions for polycystic ovary syndrome (PCOS): a comprehensive review of dietary approaches, macronutrient impact, and herbal medicine in management (2025) · cites this paper as [30]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236
DeFronzo, R. A., & Ferrannini, E. (1991) · Diabetes Care · doi:10.2337/diacare.14.3.173 · Cited by 4,535
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*
Desvergne, B., & Wahli, W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.5.0380 · Cited by 3,086
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism
Desvergne, B. (1999) · Endocrine Reviews · doi:10.1210/er.20.5.649 · Cited by 1,251
Winzell, M. S., & Ahrén, B. (2004) · Diabetes · doi:10.2337/diabetes.53.suppl_3.s215 · Cited by 1,026
Cinnamon improves glucose and lipids of people with type 2 diabetes
Khan, A., Safdar, M., Ali Khan, M. M., Khattak, K. N., & Anderson, R. A. (2003) · Diabetes Care · doi:10.2337/diacare.26.12.3215 · Cited by 981
Mayerson, A. B., Hundal, R. S., Dufour, S., Lebon, V., Befroy, D., Cline, G. W., Enocksson, S., Inzucchi, S. E., Shulman, G. I., & Petersen, K. F. (2002) · Diabetes · doi:10.2337/diabetes.51.3.797 · Cited by 647
Anderson, R. A., Broadhurst, C. L., Polansky, M. M., Schmidt, W. F., Khan, A., Flanagan, V. P., Schoene, N. W., & Graves, D. J. (2004) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf034916b · Cited by 561
Treatment of insulin resistance with peroxisome proliferator–activated receptor γ agonists
Olefsky, J. M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10843 · Cited by 537
Anti-diabetic effect of cinnamon extract on blood glucose in db/db mice
Kim, S. H., Hyun, S. H., & Choung, S. Y. (2006) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2005.08.059 · Cited by 503
Kashyap, S., Belfort, R., Gastaldelli, A., Pratipanawatr, T., Berria, R., Pratipanawatr, W., Bajaj, M., Mandarino, L., DeFronzo, R., & Cusi, K. (2003) · Diabetes · doi:10.2337/diabetes.52.10.2461 · Cited by 503
Miyazaki, Y., Mahankali, A., Matsuda, M., Glass, L., Mahankali, S., Ferrannini, E., Cusi, K., Mandarino, L. J., & DeFronzo, R. A. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.710 · Cited by 407
Effects of a cinnamon extract on plasma glucose, HbA1c, and serum lipids in diabetes mellitus type 2
Mang, B., Wolters, M., Schmitt, B., Kelb, K., Lichtinghagen, R., Stichtenoth, D. O., & Hahn, A. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01629.x · Cited by 354
Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARγ pathway
Huang, C., Zhang, Y., Gong, Z., Sheng, X., Li, Z., Zhang, W., & Qin, Y. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.07.095 · Cited by 278
Self-citationFree fatty acids, insulin resistance, and type 2 diabetes mellitus
Boden, G. (1999) · Proceedings of the Association of American Physicians · doi:10.1046/j.1525-1381.1999.99220.x · Cited by 246 · cited 1×
“Serum contents of FFA, which impair insulin secretion and induce beta-cell lipotoxicity [19] and inhibit insulin-stimulated glucose uptake into muscle [20], were also reduced notably in DIO mice.”
BackgroundTroglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients
The Troglitazone study group, Kumar, S., Boulton, A. J. M., Beck-Nielsen, H., Berthezene, F., Muggeo, M., Persson, B., Spinas, G. A., Donoghue, S., Lettis, S., et al. (1996) · Diabetologia · doi:10.1007/bf00418542 · Cited by 236
Chitturi, S., & George, J. (2002) · Seminars in Liver Disease · doi:10.1055/s-2002-30102 · Cited by 216 · cited 1×
“However, these agonists can also produce moderate to serious side effects such as edema, weight gain, congestive heart failure, and hepatotoxicity [9, 10].”
BackgroundEffect of Cinnamon on Glucose Control and Lipid Parameters
Baker, W. L., Gutierrez-Williams, G., White, C. M., Kluger, J., & Coleman, C. I. (2008) · Diabetes Care · doi:10.2337/dc07-1711 · Cited by 165
Åhrén, B., Simonsson, E., Scheurink, A. J. W., Mulder, H., Myrsén-Axcrona, U., & Sundler, F. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90175-x · Cited by 138
Talpur, N., Echard, B., Ingram, C., Bagchi, D., & Preuss, H. (2005) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00386.x · Cited by 102
Roffey, B., Atwal, A., & Kubow, S. (2006) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200500253 · Cited by 58
Pharmacotherapy of Type 2 Diabetes Mellitus
Rendell, M., & Kirchain, W. R. (2000) · Annals of Pharmacotherapy · doi:10.1345/aph.19171 · Cited by 32
Nonalcoholic fatty liver (NASH syndrome).
O'Connor, B. J., Kathamna, B., & Tavill, A. S. (1997) · PubMed · Cited by 23
[Increased liver enzymes: what should be done?].
Renner, E. L., & Dällenbach, A. (1992) · PubMed · Cited by 21
Benefits of lipid-lowering therapy in patients with type 2 diabetes mellitus
Betteridge, J. D. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.09.013 · Cited by 18
Cited by
Possible anti-obesity therapeutics from nature--a review
Yun, J. W. (2010) · Phytochemistry · doi:10.1016/j.phytochem.2010.07.011 · Cited by 619
Targeting Inflammation-Induced Obesity and Metabolic Diseases by Curcumin and Other Nutraceuticals
Aggarwal, B. B. (2010) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.012809.104755 · Cited by 471
Cinnamaldehyde in diabetes: A review of pharmacology, pharmacokinetics and safety
Zhu, R., Liu, H., Liu, C., Wang, L., Ma, R., Chen, B., Li, L., Niu, J., Fu, M., Zhang, D., et al. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.05.019 · Cited by 307
Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis
Allen, R. W., Schwartzman, E., Baker, W. L., Coleman, C. I., & Phung, O. J. (2013) · The Annals of Family Medicine · doi:10.1370/afm.1517 · Cited by 269
An Overview of Herbal Products and Secondary Metabolites Used for Management of Type Two Diabetes
Ota, A., & Ulrih, N. P. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00436 · Cited by 216
Metadata
- Authors
- Sheng, X., Zhang, Y., Gong, Z., Huang, C., & Zang, Y. Q.
- Affiliations
- Chinese Academy of Sciences (CN)
- Corresponding author
- Zang, Ying Qin
- Venue
- PPAR Research
- Publisher
- Wiley
- Published
- 2008-01
- Volume
- 2008
- Issue
- 1
- Pages
- 581348-581348
- ISSN
- 1687-4757 (ISSN-L)
- 1687-4765
- PMC
- PMC2602825
- OpenAlex
- W2066224371
- Cited by
- 203
- References
- 31
- Citations by year
- 2026: 9 · 2025: 5 · 2024: 8 · 2023: 13 · 2022: 18 · 2021: 17 · 2020: 19 · 2019: 10 · 2018: 14 · 2017: 15 · 2016: 8 · 2015: 14 · 2014: 10 · 2013: 8 · 2012: 9
- FWCI
- 3.43
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PPAR Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Chinese Academy of Sciences (2009CB919001, 07JC14011, 07DJ14005)
- Ministry of Science and Technology of the People’s Republic of China (2009CB919001, 07JC14011, 07DJ14005)
- Science and Technology Commission of Shanghai Municipality (2009CB919001, 07JC14011, 07DJ14005)
- Yitian Biotechnology (Shanghai) Co., Ltd. (2009CB919001, 07JC14011, 07DJ14005)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Natural Products and Biological Research
- Keywords
- cinnamon extract, peroxisome proliferator-activated receptors, PPARγ, PPARα, insulin resistance, lipid metabolism, obesity, db/db mice, adipocytes, GLUT4, CD36, lipoprotein lipase, acetyl-CoA oxidase, hyperlipidemia, diabetes mellitus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.